D-0309-2026 Class II Ongoing

Recalled by F.H. INVESTMENTS, Inc. (Dba Asteria Health) — Birmingham, AL

FDA drug recall D-0309-2026 was initiated by F.H. INVESTMENTS, Inc. (Dba Asteria Health) on Jan 26, 2026 and is designated Class II. Reason for recall: Presence of Foreign substance - potential presence of metal particulate matter The recall status is ongoing. Affected quantity: 22,478 pellets.

Recall details

Product Type
Drugs
Report Date
Feb 18, 2026
Initiation Date
Jan 26, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
22,478 pellets.

Product description

ESTRADIOL, 12.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79599-3012-32.

Reason for recall

Presence of Foreign substance - potential presence of metal particulate matter

Distribution pattern

Nationwide in the USA

Code information

Lot#: 253000117, Exp. 02/21/2026; 253000129, Exp. 06/12/2026; 253000130, Exp. 06/16/2026; 253000154, 253000155, Exp. 08/29/2026; 253000160, Exp. 09/10/2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0309-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0309-2026. Report a data issue: hello@regdatalab.com.